For instance, in patients with PDGFR variants, lymphoid involvement is rarely seen, while patients with FGFR1-mutated neoplasms with concomitant HE may present with a stem cell malignancy exhibiting lymphoid and myeloid involvement. This evidence concerns the gene FGFR1 and hereditary elliptocytosis.